Smith & Nephew, Inc., et al., Petitioners v. Arthrex, Inc., et al.
Case Number:
19-1452
Court:
Nature of Suit:
Firms
Companies
Sectors & Industries:
-
June 21, 2021
Justices Add More Oversight To PTAB In Arthrex Ruling
The U.S. Supreme Court on Monday held that Patent Trial and Appeal Board judges are unconstitutionally appointed but that giving the U.S. Patent and Trademark Office's director more control over their rulings will fix the problem.
-
February 26, 2021
Up Next At High Court: PTAB's Legality, Voting Rights Act
The U.S. Supreme Court is set to tackle legal questions with major consequences for the patent world and voting rights this week as it heads into the final action-packed months of its term.
-
December 23, 2020
Arthrex Tells Justices To End IPRs, Kick PTAB To Congress
The U.S. Supreme Court needs to get rid of the current inter partes review system and have Congress decide what comes next, since the Federal Circuit's attempt to remedy a leadership issue with the Patent Trial and Appeal Board created a system that's "neither impartial nor accountable," medical device company Arthrex Inc. said Wednesday.
-
December 03, 2020
Justices Warned Of 'Chaos' If They Dismantle AIA Reviews
Tech companies, generic-drug makers and intellectual property groups have urged the U.S. Supreme Court to overturn the Arthrex ruling that administrative patent judges weren't constitutionally appointed, and warned that a decision that disrupts America Invents Act reviews would cause "chaos."
-
November 25, 2020
US, Smith & Nephew Urge Justices To Overturn Arthrex
The Federal Circuit misapplied clear U.S. Supreme Court precedent when finding that administrative patent judges weren't constitutionally appointed, the government and medical tech company Smith & Nephew said Wednesday in their opening salvos for the closely watched Arthrex case.
-
October 13, 2020
Supreme Court Will Decide If PTAB Judges Are Constitutional
The U.S. Supreme Court on Tuesday said it will review the Federal Circuit's explosive decision from Arthrex v. Smith & Nephew that Patent Trial and Appeal Board judges are unconstitutionally appointed.
-
October 05, 2020
Justices Delay Arthrex Petitions, But Deny Expansion Bids
The U.S. Supreme Court on Monday put off deciding whether it will review the Federal Circuit's explosive decision that Patent Trial and Appeal Board judges are unconstitutionally appointed, but turned down two petitions aiming to expand the effects of the ruling.
-
August 07, 2020
Tracking Arthrex At The Supreme Court
Originally Published Aug. 7, 2020. Last Updated June 28, 2021 | The U.S. Supreme Court on June 21 held that Patent Trial and Appeal Board judges are wrongly appointed, and decided to make their decisions reviewable by the U.S. Patent and Trademark Office's director. Here, Law360 tracks the multitude of cases that reached the Supreme Court over this issue before the Arthrex case was decided.
-
July 09, 2020
Patent Cases To Watch In The Second Half Of 2020
A wave of U.S. Supreme Court petition denials has made 2020 a bit of a letdown for patent attorneys, but there are several high-profile cases on the horizon that could decide the fate of Patent Trial and Appeal Board judges and biosimilars law, and offer more clarity on licensing standard essential patents.
-
June 30, 2020
Justices Told Congress Must Craft PTAB Constitutional Fix
Arthrex Inc. told the U.S. Supreme Court on Tuesday that the Federal Circuit correctly held that the way Patent Trial and Appeal Board judges are appointed is unconstitutional, but that the court's purported fix didn't correct the problem, so Congress should have to rewrite the law.